BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB. Immunosenescence and human vaccine immune responses. Immun Ageing 2019;16:25. [PMID: 31528180 DOI: 10.1186/s12979-019-0164-9] [Cited by in Crossref: 200] [Cited by in F6Publishing: 206] [Article Influence: 50.0] [Reference Citation Analysis]
Number Citing Articles
1 Spacova I, Patusco R, Lebeer S, Jensen MG. Influence of biotic interventions on the immune response to vaccines in young and older adults. Clin Nutr 2023;42:216-26. [PMID: 36657219 DOI: 10.1016/j.clnu.2023.01.001] [Reference Citation Analysis]
2 Riazuddin M, Jefri MH, Butt MI, Alsalamah HI, Ali Sheikh ANM. A Case of Disseminated Herpes Zoster With Polyneuropathy Following the Third Dose of the Pfizer-BioNTech Vaccine. Cureus 2023. [DOI: 10.7759/cureus.33962] [Reference Citation Analysis]
3 Jo N, Hidaka Y, Kikuchi O, Fukahori M, Sawada T, Aoki M, Yamamoto M, Nagao M, Morita S, Nakajima TE, Muto M, Hamazaki Y. Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination. Nat Aging 2023. [DOI: 10.1038/s43587-022-00343-4] [Reference Citation Analysis]
4 Kim J, Jeon K, Hong JJ, Park S, Cho H, Park H, Kwak HW, Park H, Bang Y, Lee Y, Bae S, Kim S, Hwang K, Jung D, Cho SH, Seo SH, Kim G, Oh H, Lee H, Kim KH, Lim H, Jeon P, Lee J, Chung J, Lee S, Ko HL, Song M, Cho N, Lee Y, Hong S, Nam J. Heterologous prime-boost regimen elicits potent humoral and cell-mediated immune responses and provides complete protection against SFTSV.. [DOI: 10.21203/rs.3.rs-2420776/v1] [Reference Citation Analysis]
5 Lindgren H, Eklund J, Eneslätt K, Sjöstedt A. Kinetics of the serological response up to one year after tularemia. Front Cell Infect Microbiol 2022;12:1072703. [PMID: 36683705 DOI: 10.3389/fcimb.2022.1072703] [Reference Citation Analysis]
6 Yiang GT, Wu CC, Lu CL, Hu WC, Tsai YJ, Huang YM, Su WL, Lu KC. Endoplasmic Reticulum Stress in Elderly Patients with COVID-19: Potential of Melatonin Treatment. Viruses 2023;15. [PMID: 36680196 DOI: 10.3390/v15010156] [Reference Citation Analysis]
7 Kirste I, Hortsch S, Grunert VP, Legault H, Maglinao M, Eichenlaub U, Kashlan B, Pajon R, Jochum S. Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19. Infect Dis Ther 2023;12:177-91. [PMID: 36376733 DOI: 10.1007/s40121-022-00711-y] [Reference Citation Analysis]
8 Власенко ІО, Давтян ЛЛ. Coverage of influenza vaccination of patients with diabetes and determination of barriers for implementation of vaccination. Farm Zh 2022. [DOI: 10.32352/0367-3057.6.22.03] [Reference Citation Analysis]
9 Xu Q, Wei H, Wen S, Chen J, Lei Y, Cheng Y, Huang W, Wang D, Shu Y. Factors affecting the immunogenicity of influenza vaccines in human.. [DOI: 10.21203/rs.3.rs-2255911/v1] [Reference Citation Analysis]
10 Ramasubramanian R, Meier HCS, Vivek S, Klopack E, Crimmins EM, Faul J, Nikolich-žugich J, Thyagarajan B. Evaluation of T-cell aging-related immune phenotypes in the context of biological aging and multimorbidity in the Health and Retirement Study. Immun Ageing 2022;19:33. [DOI: 10.1186/s12979-022-00290-z] [Reference Citation Analysis]
11 Al-Danakh A, Safi M, Alradhi M, Chen Q, Baldi S, Zhu X, Yang D. Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study. Cells 2022;11. [PMID: 36429070 DOI: 10.3390/cells11223641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME; other members of the COVID-in-LTC Investigator Group. Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination. J Immunol 2022;209:1892-905. [PMID: 36426948 DOI: 10.4049/jimmunol.2200369] [Reference Citation Analysis]
13 Kim SS, Sohn J, Lee SV. Immunosenescence in Caenorhabditis elegans. Immun Ageing 2022;19:56. [DOI: 10.1186/s12979-022-00314-8] [Reference Citation Analysis]
14 Domnich A, Panatto D, Pariani E, Napoli C, Chironna M, Manini I, Rizzo C, Orsi A, Icardi G; IT-BIVE-HOSP Network Study Group. Relative effectiveness of the adjuvanted vs non-adjuvanted seasonal influenza vaccines against severe laboratory-confirmed influenza among hospitalized Italian older adults. Int J Infect Dis 2022;125:164-9. [PMID: 36332902 DOI: 10.1016/j.ijid.2022.10.041] [Reference Citation Analysis]
15 Bowirrat A. Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis. J Pers Med 2022;12. [PMID: 36579548 DOI: 10.3390/jpm12111817] [Reference Citation Analysis]
16 Avchaciov K, Antoch MP, Andrianova EL, Tarkhov AE, Menshikov LI, Burmistrova O, Gudkov AV, Fedichev PO. Unsupervised learning of aging principles from longitudinal data. Nat Commun 2022;13:6529. [PMID: 36319638 DOI: 10.1038/s41467-022-34051-9] [Reference Citation Analysis]
17 Oyebanji OA, Mylonakis E, Canaday DH. Vaccines for the prevention of COVID-19 in older adults. Infectious Disease Clinics of North America 2022. [DOI: 10.1016/j.idc.2022.11.002] [Reference Citation Analysis]
18 Tang L, Zhang Y, Wang F, Wu D, Qian Z, Zhang R, Wang A, Huang C, Wang H, Ye Y, Lu M, Wang C, Ma Y, Pan J, Li Y, Lv X, An Z, Rodewald L, Wang X, Shao Y, Wu Z, Yin Z. Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study. BMJ Open 2022;12:e063919. [DOI: 10.1136/bmjopen-2022-063919] [Reference Citation Analysis]
19 Raptis CE, Berger CT, Ciurea A, Andrey DO, Polysopoulos C, Lescuyer P, Maletic T, Riek M, Scherer A, von Loga I, Safford J, Lauper K, Möller B, Vuilleumier N, Finckh A, Rubbert-roth A. Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. Front Immunol 2022;13:1016927. [DOI: 10.3389/fimmu.2022.1016927] [Reference Citation Analysis]
20 Müller L, Andrée M, Moskorz W, Drexler I, Hauka S, Ptok J, Walotka L, Grothmann R, Hillebrandt J, Ritchie A, Peter L, Walker A, Timm J, Adams O, Schaal H. Adjusted COVID-19 booster schedules balance age-dependent differences in antibody titers benefitting risk populations. Front Aging 2022;3:1027885. [PMID: 36313184 DOI: 10.3389/fragi.2022.1027885] [Reference Citation Analysis]
21 Leroux-roels I, Maes C, Joye J, Jacobs B, Jarczowski F, Diessner A, Janssens Y, Waerlop G, Tamminen K, Heinimäki S, Blazevic V, Leroux-roels G, Klimyuk V, Adachi H, Hiruta K, Thieme F. A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine. Front Immunol 2022;13:1021500. [DOI: 10.3389/fimmu.2022.1021500] [Reference Citation Analysis]
22 Martín Martín S, Morató Agustí ML, Javierre Miranda AP, Sánchez Hernández C, Schwarz Chavarri G, Aldaz Herce P, García Iglesias C, Gómez Marco JJ, Gutiérrez Pérez MI; Grupo de Prevención de Enfermedades Infecciosas del PAPPS. [Infectious Disease Prevention Group: Update on vaccines, 2022]. Aten Primaria 2022;54 Suppl 1:102462. [PMID: 36435581 DOI: 10.1016/j.aprim.2022.102462] [Reference Citation Analysis]
23 Martin P, Gleeson S, Clarke CL, Thomson T, Edwards H, Spensley K, Mortimer P, Mcintyre S, Cox A, Pickard G, Lightstone L, Thomas D, Mcadoo SP, Kelleher P, Prendecki M, Willicombe M. Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study. The Lancet Regional Health - Europe 2022;21:100478. [DOI: 10.1016/j.lanepe.2022.100478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ates Bulut E, Badak SO, Aksoy H, Fadiloglu A, Isik AT. The Awareness and Attitude of Physicians to Older Adult Routine Vaccination Scheme. CIA 2022;Volume 17:1581-1588. [DOI: 10.2147/cia.s382311] [Reference Citation Analysis]
25 Near AM, Tse J, Young-Xu Y, Hong DK, Reyes CM. Burden of influenza hospitalization among high-risk groups in the United States. BMC Health Serv Res 2022;22:1209. [PMID: 36171601 DOI: 10.1186/s12913-022-08586-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Garnica M, Aiello A, Ligotti ME, Accardi G, Arasanz H, Bocanegra A, Blanco E, Calabrò A, Chocarro L, Echaide M, Kochan G, Fernandez-rubio L, Ramos P, Pojero F, Zareian N, Piñeiro-hermida S, Farzaneh F, Candore G, Caruso C, Escors D. How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells. IJMS 2022;23:9797. [DOI: 10.3390/ijms23179797] [Reference Citation Analysis]
27 Cunha LL, Valsecchi VADS, Ward LS. Investigating population-level immunosenescence: From bench to bedside. Front Immunol 2022;13:949928. [DOI: 10.3389/fimmu.2022.949928] [Reference Citation Analysis]
28 Xue W, Li T, Zhang S, Wang Y, Hong M, Cui L, Wang H, Zhang Y, Chen T, Zhu R, Chen Z, Zhou L, Zhang R, Cheng T, Zheng Q, Zhang J, Gu Y, Xia N, Li S. Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice. Viruses 2022;14:1785. [DOI: 10.3390/v14081785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Palatella M, Guillaume SM, Linterman MA, Huehn J. The dark side of Tregs during aging. Front Immunol 2022;13:940705. [DOI: 10.3389/fimmu.2022.940705] [Reference Citation Analysis]
30 Renia L, Goh YS, Rouers A, Le Bert N, Chia WN, Chavatte JM, Fong SW, Chang ZW, Zhuo NZ, Tay MZ, Chan YH, Tan CW, Yeo NK, Amrun SN, Huang Y, Wong JXE, Hor PX, Loh CY, Wang B, Ngoh EZX, Salleh SNM, Carissimo G, Dowla S, Lim AJ, Zhang J, Lim JME, Wang CI, Ding Y, Pada S, Sun LJ, Somani J, Lee ES, Ong DLS, Leo YS, MacAry PA, Lin RTP, Wang LF, Ren EC, Lye DC, Bertoletti A, Young BE, Ng LFP; SCOPE Cohort Study Group. Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose. Nat Commun 2022;13:4615. [PMID: 35941158 DOI: 10.1038/s41467-022-32312-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ryu KJ, Kim DH. A Toxic Anterior Segment Syndrome-like Ocular Inflammatory Reaction after COVID-19 Vaccination. J Korean Ophthalmol Soc 2022;63:625-629. [DOI: 10.3341/jkos.2022.63.7.625] [Reference Citation Analysis]
32 Soto-Perez-de-Celis E, Mislang AR, Hernández-Favela CG, Russo C, Colloca G, Williams GR, O'Hanlon S, Cooper L, O'Donovan A, Audisio RA, Cheung KL, Gironés-Sarrió R, Stauder R, Jaklitsch M, Cairo C, Gil LA Jr, Alam M, Sattar S, Kantilal K, Loh KP, Lichtman SM, Brain E, Wildiers H, Kanesvaran R, Battisti NML. Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer. J Geriatr Oncol 2022:S1879-4068(22)00171-0. [PMID: 35853816 DOI: 10.1016/j.jgo.2022.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Abouqal R, Beji M, Chakroun M, Marhoum El Filali K, Rammaoui J, Zaghden H. Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco. Front Public Health 2022;10:903376. [DOI: 10.3389/fpubh.2022.903376] [Reference Citation Analysis]
34 Guarino M, Esposito I, Portella G, Cossiga V, Loperto I, Tortora R, Cennamo M, Capasso M, Terracciano D, Galeota Lanza A, Di Somma S, Picciotto FP, Morisco F; UniNa Collaborating Group. Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients. Clin Gastroenterol Hepatol 2022;20:1534-1541.e4. [PMID: 35066136 DOI: 10.1016/j.cgh.2022.01.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
35 Budde J, Skloot G. Aging and Susceptibility to Pulmonary Disease. Compr Physiol 2022;12:3509-22. [PMID: 35766832 DOI: 10.1002/cphy.c210026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Sundaram TG, Ahmed S. AGE, AUTOIMMUNITY, AND INFLAMMATION: THE CURIOUS CASE OF IMMUNOSENESCENCE AND INFLAMM-AGING. AAEE 2022;1:28-35. [DOI: 10.56543/aaeeu.2022.1.1.04] [Reference Citation Analysis]
37 Posseme C, Llibre A, Charbit B, Bondet V, Rouilly V, Saint-André V, Boussier J, Bergstedt J, Smith N, Townsend L, Sugrue JA, Ní Cheallaigh C, Conlon N, Rotival M, Kobor MS, Mottez E, Pol S, Patin E, Albert ML, Quintana-Murci L, Duffy D; Milieu Intérieur Consortium. Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation. Cell Rep 2022;39:110989. [PMID: 35767946 DOI: 10.1016/j.celrep.2022.110989] [Reference Citation Analysis]
38 Soegiarto G, Wulandari L, Purnomosari D, Dhia Fahmita K, Ikhwan Gautama H, Tri Hadmoko S, Edwin Prasetyo M, Aulia Mahdi B, Arafah N, Prasetyaningtyas D, Prawiro Negoro P, Rosita Sigit Prakoeswa C, Endaryanto A, Gede Agung Suprabawati D, Tinduh D, Basuki Rachmad E, Astha Triyono E, Wahyuhadi J, Budi Keswardiono C, Elyana Wardani F, Mayorita F, Kristiani N, Baskoro A, Fetarayani D, Kartika Nurani W, Oceandy D. Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2. Vaccine 2022;40:4046-56. [PMID: 35660034 DOI: 10.1016/j.vaccine.2022.05.059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Hirai T, Yoshioka Y. Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses. Front Immunol 2022;13:918611. [DOI: 10.3389/fimmu.2022.918611] [Reference Citation Analysis]
40 Richardson PJ, Robinson BWS, Smith DP, Stebbing J. The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19. Vaccines (Basel) 2022;10:951. [PMID: 35746559 DOI: 10.3390/vaccines10060951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Gill PS, Ozment TR, Lewis NH, Sherwood ER, Williams DL. Trained Immunity Enhances Human Monocyte Function in Aging and Sepsis. Front Immunol 2022;13:872652. [PMID: 35693816 DOI: 10.3389/fimmu.2022.872652] [Reference Citation Analysis]
42 Wang XY, Mahmood SF, Jin F, Cheah WK, Ahmad M, Sohail MA, Ahmad W, Suppan VK, Sayeed MA, Luxmi S, Teo AH, Lee LY, Qi YY, Pei RJ, Deng W, Xu ZH, Yang JM, Zhang Y, Guan WX, Yu X. Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial. Emerg Microbes Infect 2022;:1-44. [PMID: 35686572 DOI: 10.1080/22221751.2022.2088406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Ascough S, Dayananda P, Kalyan M, Kuong SU, Gardener Z, Bergstrom E, Paterson S, Kar S, Avadhan V, Thwaites R, Sanchez Sevilla Uruchurtu A, Ruckwardt TJ, Chen M, Nair D, Derrien-Colemyn A, Graham BS, Begg M, Hessel E, Openshaw P, Chiu C. Divergent age-related humoral correlates of protection against respiratory syncytial virus infection in older and young adults: a pilot, controlled, human infection challenge model. Lancet Healthy Longev 2022;3:e405-16. [PMID: 36098319 DOI: 10.1016/S2666-7568(22)00103-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Ntouros PA, Kravvariti E, Vlachogiannis NI, Pappa M, Trougakos IP, Terpos E, Tektonidou MG, Souliotis VL, Sfikakis PP. Oxidative stress and endogenous DNA damage in blood mononuclear cells may predict anti-SARS-CoV-2 antibody titers after vaccination in older adults. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868:166393. [DOI: 10.1016/j.bbadis.2022.166393] [Reference Citation Analysis]
45 Guan L, Crasta KC, Maier AB. Assessment of cell cycle regulators in human peripheral blood cells as markers of cellular senescence. Ageing Res Rev 2022;78:101634. [PMID: 35460888 DOI: 10.1016/j.arr.2022.101634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Farid E, Herrera-uribe J, Stevenson NJ. The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine. Front Immunol 2022;13:817597. [DOI: 10.3389/fimmu.2022.817597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Breznik JA, Huynh A, Zhang A, Bilaver L, Bhakta H, Stacey HD, Ang JC, Bramson JL, Nazy I, Miller MS, Denburg J, Costa AP, Bowdish DME, other members of the COVID-in-LTC Investigator Group. CMV seropositivity in older adults changes the T cell repertoire, but does not prevent antibody or cellular responses to SARS-CoV-2 vaccination.. [DOI: 10.1101/2022.05.27.22275673] [Reference Citation Analysis]
48 Jergović M, Uhrlaub JL, Watanabe M, Bradshaw CM, White LM, LaFleur BJ, Edwards T, Sprissler R, Worobey M, Bhattacharya D, Nikolich-Žugich J. Competent immune responses to SARS-CoV-2 variants in older adults following two doses of mRNA vaccination. Nat Commun 2022;13:2891. [PMID: 35610270 DOI: 10.1038/s41467-022-30617-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Versteegen P, Barkoff A, Valente Pinto M, van de Kasteele J, Knuutila A, Bibi S, de Rond L, Teräsjärvi J, Sanders K, de Zeeuw-brouwer M, Luoto R, ten Hulscher H, Clutterbuck EA, Sanders EAM, Mertsola J, Berbers GAM, He Q, Kelly DF, Buisman A; PERISCOPE Consortium. Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries. Front Immunol 2022;13:864674. [DOI: 10.3389/fimmu.2022.864674] [Reference Citation Analysis]
50 Baber J, Arya M, Moodley Y, Jaques A, Jiang Q, Swanson KA, Cooper D, Maddur MS, Loschko J, Gurtman A, Jansen KU, Gruber WC, Dormitzer PR, Schmoele-Thoma B. A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults. J Infect Dis 2022;226:2054-63. [PMID: 35543281 DOI: 10.1093/infdis/jiac189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Jiang ZH, Wong LS, Lee CH, Hsu TJ, Yu YH. Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination. Indian J Dermatol Venereol Leprol 2022;88:445. [PMID: 35389012 DOI: 10.25259/IJDVL_819_2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bianchi FP, Tafuri S. Vaccination of Elderly People Affected by Chronic Diseases: A Challenge for Public Health. Vaccines 2022;10:641. [DOI: 10.3390/vaccines10050641] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Arregocés-castillo L, Fernández-niño J, Rojas-botero M, Palacios-clavijo A, Galvis-pedraza M, Rincón-medrano L, Pinto-álvarez M, Ruiz-gómez F, Trejo-valdivia B. Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort. The Lancet Healthy Longevity 2022;3:e242-52. [DOI: 10.1016/s2666-7568(22)00035-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
54 Kamogashira T, Funayama H, Asakura S, Ishimoto S. Vestibular Neuritis Following COVID-19 Vaccination: A Retrospective Study. Cureus 2022;14:e24277. [PMID: 35602793 DOI: 10.7759/cureus.24277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Wanlapakorn N, Suntronwong N, Phowatthanasathian H, Yorsaeng R, Thongmee T, Vichaiwattana P, Auphimai C, Wongsrisang L, Klinfueng S, Sudhinaraset N, Poovorawan Y. Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: real-world data. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.04.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Kitamura M, Takazono T, Yamamoto K, Harada T, Funakoshi S, Mukae H, Nishino T. Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case-control observational study. Ren Replace Ther 2022;8:8. [PMID: 35308296 DOI: 10.1186/s41100-022-00397-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Heikkilä N, Hetemäki I, Sormunen S, Isoniemi H, Kekäläinen E, Saramäki J, Arstila TP. Peripheral differentiation patterns of human T cells. Eur J Immunol 2022. [PMID: 35307831 DOI: 10.1002/eji.202149465] [Reference Citation Analysis]
58 Medeiros GX, Sasahara GL, Magawa JY, Nunes JPS, Bruno FR, Kuramoto AC, Almeida RR, Ferreira MA, Scagion GP, Candido ÉD, Leal FB, Oliveira DBL, Durigon EL, Silva RCV Jr, Rosa DS, Boscardin SB, Coelho V, Kalil J, Santos KS, Cunha-Neto E. Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old. Front Immunol 2022;13:812126. [PMID: 35300337 DOI: 10.3389/fimmu.2022.812126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
59 Caimi B, Franzetti M, Velleca R, Lai A, Gatti A, Rossi PL, D'Orso M, Pregliasco F, Balotta C, Calicchio G. Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention. BMC Geriatr 2022;22:191. [PMID: 35272615 DOI: 10.1186/s12877-022-02884-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
60 Kirste I, Hortsch S, Grunert VP, Legault H, Maglinao M, Eichenlaub U, Kashlan B, Pajon R, Jochum S. Quantifying the vaccine-induced humoral immune response to spike-receptor binding domain as a surrogate for neutralization testing following mRNA-1273 (Spikevax) vaccination against COVID-19.. [DOI: 10.1101/2022.03.09.22271896] [Reference Citation Analysis]
61 Le Borgne P, Dellenbach Q, Alame K, Noizet M, Gottwalles Y, Chouihed T, Abensur Vuillaume L, Lavoignet C, Bérard L, Molter L, Gennai S, Kepka S, Lefebvre F, Bilbault P. The Impact of Age on In-Hospital Mortality in Critically Ill COVID-19 Patients: A Retrospective and Multicenter Study. Diagnostics 2022;12:666. [DOI: 10.3390/diagnostics12030666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Munasinghe B, Fernando U, Mathurageethan M, Sritharan D. Reactivation of varicella-zoster virus following mRNA COVID-19 vaccination in a patient with moderately differentiated adenocarcinoma of rectum: A case report. SAGE Open Medical Case Reports 2022;10:2050313X2210777. [DOI: 10.1177/2050313x221077737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Hoff NA, Bratcher A, Kelly JD, Musene K, Kompany JP, Kabamba M, Mbala-Kingebeni P, Dighero-Kemp B, Kocher G, Elliott E, Reilly C, Halbrook M, Ilunga Kebela B, Gadoth A, Ngoie Mwamba G, Tambu M, McIlwain DR, Mukadi P, Hensley LE, Ahuka-Mundeke S, Rutherford GW, Muyembe-Tamfum JJ, Rimoin AW. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo. Proc Natl Acad Sci U S A 2022;119:e2118895119. [PMID: 35110410 DOI: 10.1073/pnas.2118895119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Moustaki A, Crawford JC, Alli S, Fan Y, Boi S, Zamora AE, McDonald NMN, Wu G, Nakitandwe J, Newman S, Foy S, Silkov A, Thomas PG, Pappo A, Dyer MA, Stewart E, Federico S, Youngblood B. Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation. Sci Immunol 2022;7:eabf6136. [PMID: 35119937 DOI: 10.1126/sciimmunol.abf6136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Ekuma UO, Ogbu O, Oli AN, Okolo MO, Edeh PA, Al-dahmoshi HOM, Akrami S, Saki M, Tharmalingam J. The Burden of Likely Rubella Infection among Healthy Pregnant Women in Abakaliki, Ebonyi State, Nigeria. Interdisciplinary Perspectives on Infectious Diseases 2022;2022:1-5. [DOI: 10.1155/2022/5743106] [Reference Citation Analysis]
66 Sandionigi A, De Giani A, Tursi F, Michelotti A, Cestone E, Giardina S, Zampolli J, Di Gennaro P, Abbassi MS. Effectiveness of Multistrain Probiotic Formulation on Common Infectious Disease Symptoms and Gut Microbiota Modulation in Flu-Vaccinated Healthy Elderly Subjects. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/3860896] [Reference Citation Analysis]
67 Snape N, Anderson GP, Irving LB, Jarnicki AG, Hurt AC, Collins T, Xi Y, Upham JW. Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people. NPJ Vaccines 2022;7:8. [PMID: 35075113 DOI: 10.1038/s41541-021-00422-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Bakasis A, Bitzogli K, Mouziouras D, Pouliakis A, Roumpoutsou M, Goules AV, Androutsakos T. Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases. Viruses 2022;14:207. [DOI: 10.3390/v14020207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
69 Plüß M, Mese K, Kowallick JT, Schuster A, Tampe D, Tampe B. Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2. Front Immunol 2022;12:784145. [DOI: 10.3389/fimmu.2021.784145] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
70 Bleve A, Motta F, Durante B, Pandolfo C, Selmi C, Sica A. Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases. Clin Rev Allergy Immunol 2022. [PMID: 35031957 DOI: 10.1007/s12016-021-08909-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
71 Vitallé J, Pérez-gómez A, Ostos FJ, Gasca-capote C, Jiménez-león MR, Bachiller S, Rivas-jeremías I, del Mar Silva-sánchez M, Ruiz-mateos A, López-cortes LF, Rafii-el-idrissi Benhnia M, Ruiz-mateos E. Innate and adaptive immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people.. [DOI: 10.1101/2022.01.07.22268806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Fernández-Ferreiro A, Formigo-Couceiro FJ, Veiga-Gutierrez R, Maldonado-Lobón JA, Hermida-Cao AM, Rodriguez C, Bañuelos O, Olivares M, Blanco-Rojo R. Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial. Nutrients 2022;14:228. [PMID: 35011103 DOI: 10.3390/nu14010228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
73 Bohn-Goldbaum E, Cross T, Leeb A, Peters I, Booy R, Edwards KM. Adverse events following influenza immunization: understanding the role of age and sex interactions. Expert Rev Vaccines 2022;:1-8. [PMID: 34937488 DOI: 10.1080/14760584.2022.2021075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Weinberger B. Vaccines and Vaccination Strategies for Older Adults. Healthy Ageing and Longevity 2022. [DOI: 10.1007/978-3-030-87532-9_7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Hu W, Sjoberg PA, DeMarcus LS, Robbins AS. Influenza Vaccine Effectiveness Estimates among US Department of Defense Adult Beneficiaries over Four Consecutive Influenza Seasons: A Test-Negative Design Study with Different Control Groups. Vaccines (Basel) 2021;10:58. [PMID: 35062721 DOI: 10.3390/vaccines10010058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Park BR, Subbiah J, Kim KH, Kwon YM, Oh J, Kim MC, Shin CH, Seong BL, Kang SM. Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes. Virology 2022;566:143-52. [PMID: 34929590 DOI: 10.1016/j.virol.2021.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Lee SW, Moon JY, Lee SK, Lee H, Moon S, Chung SJ, Yeo Y, Park TS, Park DW, Kim TH, Sohn JW, Yoon HJ, Kim SH. Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions. Front Immunol 2021;12:779212. [PMID: 34899739 DOI: 10.3389/fimmu.2021.779212] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
78 Near A, Tse J, Young-xu Y, Hong DK, Reyes CM. Burden of influenza hospitalization among high-risk groups in the United States.. [DOI: 10.1101/2021.12.10.21267528] [Reference Citation Analysis]
79 Demaret J, Corroyer-Simovic B, Alidjinou EK, Goffard A, Trauet J, Miczek S, Vuotto F, Dendooven A, Huvent-Grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Labreuche J, Sobaszek A, Hisbergues M, Puisieux F, Labalette M, Lefèvre G. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People. Front Immunol 2021;12:778679. [PMID: 34868051 DOI: 10.3389/fimmu.2021.778679] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
80 Weinberger B. Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population. Vaccines (Basel) 2021;9:1435. [PMID: 34960181 DOI: 10.3390/vaccines9121435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Lanfermeijer J, Nühn MM, Emmelot ME, Poelen MCM, van Els CACM, Borghans JAM, van Baarle D, Kaaijk P, de Wit J. Longitudinal Characterization of the Mumps-Specific HLA-A2 Restricted T-Cell Response after Mumps Virus Infection. Vaccines (Basel) 2021;9:1431. [PMID: 34960178 DOI: 10.3390/vaccines9121431] [Reference Citation Analysis]
82 Smith PL, Piadel K, Dalgleish AG. Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy. Vaccines (Basel) 2021;9:1392. [PMID: 34960140 DOI: 10.3390/vaccines9121392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Swaminathan G, Citron M, Xiao J, Norton JE Jr, Reens AL, Topçuoğlu BD, Maritz JM, Lee KJ, Freed DC, Weber TM, White CH, Kadam M, Spofford E, Bryant-Hall E, Salituro G, Kommineni S, Liang X, Danilchanka O, Fontenot JA, Woelk CH, Gutierrez DA, Hazuda DJ, Hannigan GD. Vaccine Hyporesponse Induced by Individual Antibiotic Treatment in Mice and Non-Human Primates Is Diminished upon Recovery of the Gut Microbiome. Vaccines (Basel) 2021;9:1340. [PMID: 34835271 DOI: 10.3390/vaccines9111340] [Reference Citation Analysis]
84 Maldonado MD, Romero-Aibar J. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus. Brain Behav Immun Health 2021;18:100381. [PMID: 34746880 DOI: 10.1016/j.bbih.2021.100381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
85 Pallikkuth S, Mendez R, Russell K, Sirupangi T, Kvistad D, Pahwa R, Villinger F, Banerjee S, Pahwa S. Age Associated Microbiome and Microbial Metabolites Modulation and Its Association With Systemic Inflammation in a Rhesus Macaque Model. Front Immunol 2021;12:748397. [PMID: 34737748 DOI: 10.3389/fimmu.2021.748397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Oyebanji OA, Wilson B, Keresztesy D, Carias L, Wilk D, Payne M, Aung H, Denis KS, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Schmader KE, Balazs AB, King CL, Canaday DH, Gravenstein S. Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents? Aging Clin Exp Res 2021;33:3151-60. [PMID: 34652783 DOI: 10.1007/s40520-021-01987-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
87 Alarcon PC, Damen MSMA, Madan R, Deepe GS Jr, Spearman P, Way SS, Divanovic S. Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution. Mucosal Immunol 2021;14:1224-34. [PMID: 33958704 DOI: 10.1038/s41385-021-00404-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
88 Veronese N, Petrovic M, Benetos A, Denkinger M, Gudmundsson A, Knol W, Marking C, Soulis G, Maggi S, Cherubini A; special interest group in Systematic Reviews and Meta-analyses and the task force on Pharmaceutical strategy of the European Geriatric Medicine Society (EuGMS). Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review. Ageing Res Rev 2021;71:101455. [PMID: 34487916 DOI: 10.1016/j.arr.2021.101455] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
89 Buchy P, Buisson Y, Cintra O, Dwyer DE, Nissen M, Ortiz de Lejarazu R, Petersen E. COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control. Int J Infect Dis 2021;112:300-17. [PMID: 34563707 DOI: 10.1016/j.ijid.2021.09.045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
90 Lalinde-Ruiz N, Rodríguez IJ, Bernal-Estévez DA, Parra-López CA. Young but not older adults exhibit an expansion of CD45RA+CCR7+CD95+ T follicular helper cells in response to tetanus vaccine. Exp Gerontol 2021;156:111599. [PMID: 34688830 DOI: 10.1016/j.exger.2021.111599] [Reference Citation Analysis]
91 Antonelli-Incalzi R, Blasi F, Conversano M, Gabutti G, Giuffrida S, Maggi S, Marano C, Rossi A, Vicentini M. Manifesto on the Value of Adult Immunization: "We Know, We Intend, We Advocate". Vaccines (Basel) 2021;9:1232. [PMID: 34835163 DOI: 10.3390/vaccines9111232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
92 Ligotti ME, Pojero F, Accardi G, Aiello A, Caruso C, Duro G, Candore G. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? Front Cell Dev Biol 2021;9:725606. [PMID: 34595175 DOI: 10.3389/fcell.2021.725606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
93 Jergović M, Coplen CP, Uhrlaub JL, Nikolich-Žugich J. Immune response to COVID-19 in older adults. J Heart Lung Transplant 2021;40:1082-9. [PMID: 34140221 DOI: 10.1016/j.healun.2021.04.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
94 Shields AM, Faustini SE, Perez-Toledo M, Jossi S, Allen JD, Al-Taei S, Backhouse C, Dunbar LA, Ebanks D, Emmanuel B, Faniyi AA, Garvey M, Grinbergs A, McGinnell G, O'Neill J, Watanabe Y, Crispin M, Wraith DC, Cunningham AF, Drayson MT, Richter AG. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response. BMJ Open Respir Res 2021;8:e000872. [PMID: 34561239 DOI: 10.1136/bmjresp-2020-000872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
95 Wall N, Godlee A, Geh D, Jones C, Faustini S, Harvey R, Penn R, Chanouzas D, Nightingale P, O'Shea M, Richter A, Moss P, Cunningham A, Harper L. Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease. Clin Infect Dis 2021;73:e880-9. [PMID: 33728434 DOI: 10.1093/cid/ciab078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
96 St Sauver JL, Lopes GS, Rocca WA, Prasad K, Majerus MR, Limper AH, Jacobson DJ, Fan C, Jacobson RM, Rutten LJ, Norman AD, Vachon CM. Factors Associated With Severe COVID-19 Infection Among Persons of Different Ages Living in a Defined Midwestern US Population. Mayo Clin Proc 2021;96:2528-39. [PMID: 34538426 DOI: 10.1016/j.mayocp.2021.06.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
97 Lee HK, Knabl L, Knabl L Sr, Kapferer S, Pateter B, Walter M, Furth PA, Hennighausen L. Robust immune response to the BNT162b mRNA vaccine in an elderly population vaccinated 15 months after recovery from COVID-19. medRxiv 2021:2021. [PMID: 34545374 DOI: 10.1101/2021.09.08.21263284] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
98 Katsikas Triantafyllidis K, Giannos P, Mian IT, Kyrtsonis G, Kechagias KS. Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports. Vaccines (Basel) 2021;9:1013. [PMID: 34579250 DOI: 10.3390/vaccines9091013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
99 Song G, Yang H, Shen N, Pham P, Brown B, Lin X, Hong Y, Sinu P, Cai J, Li X, Leon M, Gordon MN, Morgan D, Zhang S, Cao C. An Immunomodulatory Therapeutic Vaccine Targeting Oligomeric Amyloid-β. J Alzheimers Dis 2020;77:1639-53. [PMID: 32925044 DOI: 10.3233/JAD-200413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
100 Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov 2021;20:817-38. [PMID: 34433919 DOI: 10.1038/s41573-021-00283-5] [Cited by in Crossref: 167] [Cited by in F6Publishing: 187] [Article Influence: 83.5] [Reference Citation Analysis]
101 Crooke SN, Goergen KM, Ovsyannikova IG, Kennedy RB. Inflammasome Activity in Response to Influenza Vaccination Is Maintained in Monocyte-Derived Peripheral Blood Macrophages in Older Adults. Front Aging 2021;2. [DOI: 10.3389/fragi.2021.719103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Shintouo CM, Shey RA, Mets T, Vanhamme L, Souopgui J, Ghogomu SM, Njemini R. Onchocerciasis Fingerprints in the Geriatric Population: Does Host Immunity Play a Role? Trop Med Infect Dis 2021;6:153. [PMID: 34449738 DOI: 10.3390/tropicalmed6030153] [Reference Citation Analysis]
103 Rosenstein MD, de Visser AW, Visser LG, Roukens AHE. Long-term immunity after a single yellow fever vaccination in travelers vaccinated at 60 years or older: A 10-year follow-up study. J Travel Med 2021:taab126. [PMID: 34401911 DOI: 10.1093/jtm/taab126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
104 da Silva IDCG, Marchioni DML, Carioca AAF, Bueno V, Colleoni GWB. May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control? Immun Ageing 2021;18:33. [PMID: 34389039 DOI: 10.1186/s12979-021-00244-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Frasca D, Diaz A, Romero M, Garcia D, Blomberg BB. B Cell Immunosenescence. Annu Rev Cell Dev Biol 2020;36:551-74. [PMID: 33021823 DOI: 10.1146/annurev-cellbio-011620-034148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
106 Abreu RB, Kirchenbaum GA, Sautto GA, Clutter EF, Ross TM. Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination. PLoS One 2021;16:e0254421. [PMID: 34351920 DOI: 10.1371/journal.pone.0254421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
107 Wen S, Wu Z, Zhong S, Li M, Shu Y. Factors influencing the immunogenicity of influenza vaccines. Hum Vaccin Immunother 2021;17:2706-18. [PMID: 33705263 DOI: 10.1080/21645515.2021.1875761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Ramos EH, Suárez VM, Hernández IC, Gomez RP, Rivera DG, Zamora MCR, Monteagudo AC, Marrero YT, Domínguez GD, Pérez YD, Abraham CM, Pita AMS. Effect of Biomodulina-T® and VA-MENGOC-BC® on lymphocyte subpopulations in older adults. Exp Gerontol 2021;153:111497. [PMID: 34325009 DOI: 10.1016/j.exger.2021.111497] [Reference Citation Analysis]
109 Jergović M, Uhrlaub JL, Watanabe M, Bradshaw CM, White LM, Lafleur BJ, Edwards T, Sprissler R, Worobey M, Bhattacharya D, Nikolich-žugich J. Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccination.. [DOI: 10.1101/2021.07.22.453287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Illouz T, Madar R, Hirsh T, Biragyn A, Okun E. Induction of an effective anti-Amyloid-β humoral response in aged mice. Vaccine 2021;39:4817-29. [PMID: 34294479 DOI: 10.1016/j.vaccine.2021.07.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Lin X, Lin F, Liang T, Ducatez MF, Zanin M, Wong SS. Antibody Responsiveness to Influenza: What Drives It? Viruses 2021;13:1400. [PMID: 34372607 DOI: 10.3390/v13071400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
112 Clarke CL, Martin P, Gleeson S, Thomson T, Edwards H, Mortimer P, Mcintyre S, Deborah J, Cox A, Pickard G, Lightstone L, Thomas D, Mcadoo SP, Kelleher P, Prendecki M, Willicombe M, in collaboration with the OCTAVE Study Consortium. Comparison of immunogenicity between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in a large haemodialysis population.. [DOI: 10.1101/2021.07.09.21260089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
113 Rzymski P, Pazgan-Simon M, Simon K, Łapiński T, Zarębska-Michaluk D, Szczepańska B, Chojnicki M, Mozer-Lisewska I, Flisiak R. Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine. Vaccines (Basel) 2021;9:781. [PMID: 34358197 DOI: 10.3390/vaccines9070781] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
114 Walkiewicz D, Wicik Z, Puzianowska-Kuznicka M. Gonadotropin-releasing hormone receptor pathway affects the function of human EBV-transformed B lymphocytes in an age-independent way. Exp Gerontol 2021;152:111471. [PMID: 34256116 DOI: 10.1016/j.exger.2021.111471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Demaret J, Corroyer-simovic B, Alidjinou EK, Goffard A, Trauet J, Miczek S, Vuotto F, Dendooven A, Huvent-grelle D, Podvin J, Dreuil D, Faure K, Deplanque D, Bocket L, Duhamel A, Labreuche J, Sobaszek A, Puisieux F, Labalette M, Lefèvre G. Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection.. [DOI: 10.1101/2021.07.08.451426] [Reference Citation Analysis]
116 Jung J, Mundle ST, Ustyugova IV, Horton AP, Boutz DR, Pougatcheva S, Prabakaran P, McDaniel JR, King GR, Park D, Person MD, Ye C, Tan B, Tanno Y, Kim JE, Curtis NC, DiNapoli J, Delagrave S, Ross TM, Ippolito GC, Kleanthous H, Lee J, Georgiou G. Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans. J Clin Invest 2021;131:148763. [PMID: 34196304 DOI: 10.1172/JCI148763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
117 Illouz T, Biragyn A, Iulita MF, Flores-Aguilar L, Dierssen M, De Toma I, Antonarakis SE, Yu E, Herault Y, Potier MC, Botté A, Roper R, Sredni B, London J, Mobley W, Strydom A, Okun E. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome. Front Immunol 2021;12:621440. [PMID: 34248930 DOI: 10.3389/fimmu.2021.621440] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
118 Livermore DM. Antibiotic resistance during and beyond COVID-19. JAC Antimicrob Resist 2021;3:i5-i16. [PMID: 34223149 DOI: 10.1093/jacamr/dlab052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
119 Iacono D, Cerbone L, Palombi L, Cavalieri E, Sperduti I, Cocchiara RA, Mariani B, Parisi G, Garufi C. Serological response to COVID-19 vaccination in patients with cancer older than 80 years. J Geriatr Oncol 2021:S1879-4068(21)00136-3. [PMID: 34175246 DOI: 10.1016/j.jgo.2021.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
120 Schwarz T, Tober-Lau P, Hillus D, Helbig ET, Lippert LJ, Thibeault C, Koch W, Landgraf I, Michel J, Bergfeld L, Niemeyer D, Mühlemann B, Conrad C, Dang-Heine C, Kasper S, Münn F, Kappert K, Nitsche A, Tauber R, Schmidt S, Kopankiewicz P, Bias H, Seybold J, von Kalle C, Jones TC, Suttorp N, Drosten C, Sander LE, Corman VM, Kurth F. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis 2021;27:2174-8. [PMID: 34102097 DOI: 10.3201/eid2708.211145] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 20.5] [Reference Citation Analysis]
121 Bang YJ, Hong SH, Park HJ, Kwak HW, Lee YS, Kim JY, Park HJ, Bae SH, Kim HJ, Kim YH, Ko HL, Park SI, Kim H, Park G, Park MS, Chang J, Nam JH. Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant. Sci Rep 2021;11:11981. [PMID: 34099809 DOI: 10.1038/s41598-021-91445-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Lanfermann C, Wintgens S, Ebensen T, Kohn M, Laudeley R, Schulze K, Rheinheimer C, Hegemann JH, Guzmán CA, Klos A. Prophylactic Multi-Subunit Vaccine against Chlamydia trachomatis: In Vivo Evaluation in Mice. Vaccines (Basel) 2021;9:609. [PMID: 34204170 DOI: 10.3390/vaccines9060609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Li X, Feng B, Jia X, Guo X, He Z, Liu T, Yu W, Ming W, Wu Y. COVID-19 vaccine acceptance among Chinese and American middle-aged and elderly adults:A discrete choice experiment and propensity score matching study (Preprint).. [DOI: 10.2196/preprints.30958] [Reference Citation Analysis]
124 Psichogiou M, Samarkos M, Mikos N, Hatzakis A. Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2. Vaccines (Basel) 2021;9:572. [PMID: 34205861 DOI: 10.3390/vaccines9060572] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 29.5] [Reference Citation Analysis]
125 Batista-Duharte A, Pera A, Aliño SF, Solana R. Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects. Int Immunopharmacol 2021;96:107761. [PMID: 34162139 DOI: 10.1016/j.intimp.2021.107761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
126 Silverio R, Gonçalves DC, Andrade MF, Seelaender M. Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link? Adv Nutr 2021;12:682-92. [PMID: 32975565 DOI: 10.1093/advances/nmaa125] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 16.0] [Reference Citation Analysis]
127 Falsey AR. A glimmer of hope for the most vulnerable. J Am Geriatr Soc 2021;69:1710-2. [PMID: 33872381 DOI: 10.1111/jgs.17198] [Reference Citation Analysis]
128 Sandor AM, Sturdivant MS, Ting JPY. Influenza Virus and SARS-CoV-2 Vaccines. J Immunol 2021;206:2509-20. [PMID: 34021048 DOI: 10.4049/jimmunol.2001287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
129 Chen M, Werner F, Wagner C, Simon M, Richtig E, Mertz KD, Griss J, Wagner SN. Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics. Front Cell Dev Biol 2021;9:677944. [PMID: 34095149 DOI: 10.3389/fcell.2021.677944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
130 Martín MC, Jurado A, Abad-Molina C, Orduña A, Yarce O, Navas AM, Cunill V, Escobar D, Boix F, Burillo-Sanz S, Vegas-Sánchez MC, Jiménez-de Las Pozas Y, Melero J, Aguilar M, Sobieschi OI, López-Hoyos M, Ocejo-Vinyals G, San Segundo D, Almeida D, Medina S, Fernández L, Vergara E, Quirant B, Martínez-Cáceres E, Boiges M, Alonso M, Esparcia-Pinedo L, López-Sanz C, Muñoz-Vico J, López-Palmero S, Trujillo A, Álvarez P, Prada Á, Monzón D, Ontañón J, Marco FM, Mora S, Rojo R, González-Martínez G, Martínez-Saavedra MT, Gil-Herrera J, Cantenys-Molina S, Hernández M, Perurena-Prieto J, Rodríguez-Bayona B, Martínez A, Ocaña E, Molina J. The age again in the eye of the COVID-19 storm: evidence-based decision making. Immun Ageing 2021;18:24. [PMID: 34016150 DOI: 10.1186/s12979-021-00237-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
131 Canaday DH, Carias L, Oyebanji OA, Keresztesy D, Wilk D, Payne M, Aung H, St Denis K, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Wilson B, Balazs AB, Gravenstein S, King CL. Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents. Clin Infect Dis 2021:ciab447. [PMID: 33993265 DOI: 10.1093/cid/ciab447] [Cited by in Crossref: 40] [Cited by in F6Publishing: 50] [Article Influence: 20.0] [Reference Citation Analysis]
132 Xu D, Wu Y, Gao C, Qin Y, Zhao X, Liang Z, Wang Y, Feng M, Zhang C, Liu G, Luo J. Characteristics of and reference ranges for peripheral blood lymphocytes and CD4+ T cell subsets in healthy adults in Shanxi Province, North China. J Int Med Res 2020;48:300060520913149. [PMID: 32649852 DOI: 10.1177/0300060520913149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Palacios-Pedrero MÁ, Osterhaus ADME, Becker T, Elbahesh H, Rimmelzwaan GF, Saletti G. Aging and Options to Halt Declining Immunity to Virus Infections. Front Immunol 2021;12:681449. [PMID: 34054872 DOI: 10.3389/fimmu.2021.681449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
134 Biswas A, Mandal RS, Chakraborty S, Maiti G. Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population. Int Rev Immunol 2021;:1-16. [PMID: 33978550 DOI: 10.1080/08830185.2021.1925267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
135 Andryukov BG, Besednova NN. Older adults: panoramic view on the COVID-19 vaccination. AIMS Public Health 2021;8:388-415. [PMID: 34395690 DOI: 10.3934/publichealth.2021030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
136 Townsend L, Dyer AH, Naughton A, Kiersey R, Holden D, Gardiner M, Dowds J, O'Brien K, Bannan C, Nadarajan P, Dunne J, Martin-Loeches I, Fallon PG, Bergin C, O'Farrelly C, Cheallaigh CN, Bourke NM, Conlon N. Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health. Front Immunol 2021;12:676932. [PMID: 34025675 DOI: 10.3389/fimmu.2021.676932] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
137 Solforosi L, Kuipers H, Jongeneelen M, Rosendahl Huber SK, van der Lubbe JEM, Dekking L, Czapska-Casey DN, Izquierdo Gil A, Baert MRM, Drijver J, Vaneman J, van Huizen E, Choi Y, Vreugdenhil J, Kroos S, de Wilde AH, Kourkouta E, Custers J, van der Vlugt R, Veldman D, Huizingh J, Kaszas K, Dalebout TJ, Myeni SK, Kikkert M, Snijder EJ, Barouch DH, Böszörményi KP, Stammes MA, Kondova I, Verschoor EJ, Verstrepen BE, Koopman G, Mooij P, Bogers WMJM, van Heerden M, Muchene L, Tolboom JTBM, Roozendaal R, Brandenburg B, Schuitemaker H, Wegmann F, Zahn RC. Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP. J Exp Med 2021;218:e20202756. [PMID: 33909009 DOI: 10.1084/jem.20202756] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
138 Müller L, Andrée M, Moskorz W, Drexler I, Walotka L, Grothmann R, Ptok J, Hillebrandt J, Ritchie A, Rabl D, Ostermann PN, Robitzsch R, Hauka S, Walker A, Menne C, Grutza R, Timm J, Adams O, Schaal H. Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination. Clin Infect Dis 2021:ciab381. [PMID: 33906236 DOI: 10.1093/cid/ciab381] [Cited by in Crossref: 182] [Cited by in F6Publishing: 241] [Article Influence: 91.0] [Reference Citation Analysis]
139 Rees-spear C, Mccoy LE. Vaccine responses in ageing and chronic viral infection. Oxford Open Immunology 2021;2:iqab007. [DOI: 10.1093/oxfimm/iqab007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Betjes MGH. Uremia-Associated Immunological Aging and Severity of COVID-19 Infection. Front Med (Lausanne) 2021;8:675573. [PMID: 33937299 DOI: 10.3389/fmed.2021.675573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
141 Alle Q, Le Borgne E, Milhavet O, Lemaitre JM. Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues. Int J Mol Sci 2021;22:3990. [PMID: 33924362 DOI: 10.3390/ijms22083990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
142 Picard E, Bowdish DME, McElhaney JE, Pawelec G, Loeb M, Verschoor CP. The frequency of interleukin-1β-producing monocytes is significantly associated with varicella-zoster responses of nursing home residents. Clin Exp Immunol 2021;205:63-74. [PMID: 33714219 DOI: 10.1111/cei.13593] [Reference Citation Analysis]
143 Swaminathan G, Citron M, Xiao J, Norton JE, Reens AL, Topçuoğlu BD, Maritz JM, Lee K, Freed DC, Weber TM, White CH, Kadam M, Spofford E, Bryant-hall E, Salituro G, Kommineni S, Liang X, Danilchanka O, Fontenot JA, Woelk CH, Gutierrez DA, Hazuda DJ, Hannigan GD. Vaccine Hyporesponse Induced By Individual Antibiotic Treatment In Mice And Non-Human Primates Is Diminished Upon Recovery Of The Gut Microbiome.. [DOI: 10.1101/2021.04.02.438241] [Reference Citation Analysis]
144 Salmerón Ríos S, Mas Romero M, Cortés Zamora EB, Tabernero Sahuquillo MT, Romero Rizos L, Sánchez-Jurado PM, Sánchez-Nievas G, Señalada JJB, García Nogueras I, Estrella Cazalla JD, Andrés-Pretel F, Murillo Romero A, Lauschke VM, Stebbing J, Abizanda P. Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study. J Am Geriatr Soc 2021;69:1441-7. [PMID: 33768521 DOI: 10.1111/jgs.17153] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 21.5] [Reference Citation Analysis]
145 Xie X, Shrimpton J, Doody GM, Conaghan PG, Ponchel F. B-cell capacity for differentiation changes with age. Aging Cell 2021;20:e13341. [PMID: 33711204 DOI: 10.1111/acel.13341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
146 Boerwinkle AH, Strain JF, Burdo T, Doyle J, Christensen J, Su Y, Wisch JK, Cooley SA, Vaida F, Smith MD, Jafri H, Paul RH, Benzinger TLS, Ances BM. Comparison of [11C]-PBR28 Binding Between Persons Living With HIV and HIV-Uninfected Individuals. J Acquir Immune Defic Syndr 2020;85:244-51. [PMID: 32658129 DOI: 10.1097/QAI.0000000000002435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
147 Mustafin RN, Khusnutdinova EK. COVID-19, Retroelements, and Aging. Adv Gerontol 2021;11:83-92. [DOI: 10.1134/s2079057021010458] [Reference Citation Analysis]
148 Newland R, Green D, Waterall J. Nurses' role in curbing the pandemic affirms their wider remit in disease prevention and promoting vaccination. Br J Nurs 2021;30:382-3. [PMID: 33769876 DOI: 10.12968/bjon.2021.30.6.382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Antonelli Incalzi R, Trevisan C, Del Signore S, Volpato S, Fumagalli S, Monzani F, Bellelli G, Gareri P, Mossello E, Malara A, Coin A, Zia G, Ranhoff AH. Are vaccines against COVID-19 tailored to the most vulnerable people? Vaccine 2021;39:2325-7. [PMID: 33810907 DOI: 10.1016/j.vaccine.2021.03.066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
150 Weerasuriya CK, Harris RC, Quaife M, McQuaid CF, White RG, Gomez GB. Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis. Vaccines (Basel) 2021;9:245. [PMID: 33799544 DOI: 10.3390/vaccines9030245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
151 Walker JL, Grint DJ, Strongman H, Eggo RM, Peppa M, Minassian C, Mansfield KE, Rentsch CT, Douglas IJ, Mathur R, Wong AYS, Quint JK, Andrews N, Bernal JL, Scott JA, Ramsay M, Smeeth L, McDonald HI. UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records. BMC Public Health 2021;21:484. [PMID: 33706738 DOI: 10.1186/s12889-021-10427-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
152 Otero-Romero S, Sánchez-Montalvá A, Vidal-Jordana A. Assessing and mitigating risk of infection in patients with multiple sclerosis on disease modifying treatment. Expert Rev Clin Immunol 2021;17:285-300. [PMID: 33543657 DOI: 10.1080/1744666X.2021.1886924] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
153 Su YJ, Wang PW, Weng SW. The Role of Mitochondria in Immune-Cell-Mediated Tissue Regeneration and Ageing. Int J Mol Sci 2021;22:2668. [PMID: 33800867 DOI: 10.3390/ijms22052668] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
154 Mislang AR, Soto-Perez-de-Celis E, Russo C, Colloca G, Williams GR, O'Hanlon S, Cooper L, O'Donovan A, Audisio RA, Cheung KL, Sarrió RG, Stauder R, Jaklitsch M, Cairo C, Gil LA Jr, Sattar S, Kantilal K, Loh KP, Lichtman SM, Brain E, Wildiers H, Kanesvaran R, Battisti NML. The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer. J Geriatr Oncol 2021;12:848-50. [PMID: 33715995 DOI: 10.1016/j.jgo.2021.03.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
155 Topham DJ, DeDiego ML, Nogales A, Sangster MY, Sant A. Immunity to Influenza Infection in Humans. Cold Spring Harb Perspect Med 2021;11:a038729. [PMID: 31871226 DOI: 10.1101/cshperspect.a038729] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
156 Wang L, Verschuuren EAM, Paap D, Rondaan C, Raveling-Eelsing E, Liu S, Westra J, Bos NA. Ageing of Immune System and Response to a Live-Attenuated Herpes Zoster Vaccine in Lung Transplant Candidates. Vaccines (Basel) 2021;9:202. [PMID: 33671003 DOI: 10.3390/vaccines9030202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Cunningham AL, McIntyre P, Subbarao K, Booy R, Levin MJ. Vaccines for older adults. BMJ 2021;372:n188. [PMID: 33619170 DOI: 10.1136/bmj.n188] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
158 Pawelec G, McElhaney J. Unanticipated efficacy of SARS-CoV-2 vaccination in older adults. Immun Ageing 2021;18:7. [PMID: 33596958 DOI: 10.1186/s12979-021-00219-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
159 Gustafson CE, Kim C, Weyand CM, Goronzy JJ. Influence of immune aging on vaccine responses. J Allergy Clin Immunol 2020;145:1309-21. [PMID: 32386655 DOI: 10.1016/j.jaci.2020.03.017] [Cited by in Crossref: 115] [Cited by in F6Publishing: 125] [Article Influence: 57.5] [Reference Citation Analysis]
160 Shi M, Chu F, Tian X, Aerqin Q, Zhu F, Zhu J. Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer's Disease: Are Immunotherapies Effective or Off-Target? Neuroscientist 2021;:1073858420987224. [PMID: 33530843 DOI: 10.1177/1073858420987224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
161 Rocamora-Reverte L, Melzer FL, Würzner R, Weinberger B. The Complex Role of Regulatory T Cells in Immunity and Aging. Front Immunol 2020;11:616949. [PMID: 33584708 DOI: 10.3389/fimmu.2020.616949] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
162 Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol 2020;11:571416. [PMID: 33510644 DOI: 10.3389/fphys.2020.571416] [Cited by in Crossref: 158] [Cited by in F6Publishing: 170] [Article Influence: 79.0] [Reference Citation Analysis]
163 Jabr Alwazzeh M, Mohammed Telmesani L, Saud AlEnazi A, Abdulwahab Buohliqah L, Talal Halawani R, Jatoi NA, Subbarayalu AV, Abdulaziz Almuhanna F. Seasonal influenza vaccination coverage and its association with COVID-19 in Saudi Arabia. Inform Med Unlocked 2021;27:100809. [PMID: 34869828 DOI: 10.1016/j.imu.2021.100809] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
164 Caruso C, Aiello A, Pawelec G, Ligotti ME. Vaccination in old age: Challenges and promises. Human Aging 2021. [DOI: 10.1016/b978-0-12-822569-1.00020-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Bosco N, Noti M. The aging gut microbiome and its impact on host immunity. Genes Immun 2021;22:289-303. [DOI: 10.1038/s41435-021-00126-8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 42.5] [Reference Citation Analysis]
166 Omarjee L, Perrot F, Meilhac O, Mahe G, Bousquet G, Janin A. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19. Aging (Albany NY). 2020;12:26263-26278. [PMID: 33361522 DOI: 10.18632/aging.202422] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
167 Posseme C, Llibre A, Charbit B, Bondet V, Rouilly V, Saint-andré V, Boussier J, Bergstedt J, Smith N, Rotival M, Kobor MS, Scriba T, Mottez E, Pol S, Patin E, Albert ML, Quintana-murci L, Duffy D, Milieu Intérieur Consortium. Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation in health and disease.. [DOI: 10.1101/2020.12.19.20248132] [Reference Citation Analysis]
168 Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol 2021;21:83-100. [PMID: 33353987 DOI: 10.1038/s41577-020-00479-7] [Cited by in Crossref: 296] [Cited by in F6Publishing: 318] [Article Influence: 98.7] [Reference Citation Analysis]
169 Townsend L, Dyer AH, Naughton A, Kiersey R, Holden D, Gardiner M, Dowds J, O’brien K, Bannan C, Nadarajan P, Dunne J, Martin-loeches I, Fallon PG, Bergin C, O’farrelly C, Ni Cheallaigh C, Bourke NM, Conlon N. Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health.. [DOI: 10.1101/2020.12.17.20248401] [Reference Citation Analysis]
170 Fink G, Orlova-Fink N, Schindler T, Grisi S, Ferrer APS, Daubenberger C, Brentani A. Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evid Based Med 2020:bmjebm-2020-111549. [PMID: 33310766 DOI: 10.1136/bmjebm-2020-111549] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 17.7] [Reference Citation Analysis]
171 Pereira NL, Ahmad F, Byku M, Cummins NW, Morris AA, Owens A, Tuteja S, Cresci S. COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine. Mayo Clin Proc 2021;96:446-63. [PMID: 33549263 DOI: 10.1016/j.mayocp.2020.11.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
172 Fahlberg MD, Blair RV, Doyle-Meyers LA, Midkiff CC, Zenere G, Russell-Lodrigue KE, Monjure CJ, Haupt EH, Penney TP, Lehmicke G, Threeton BM, Golden N, Datta PK, Roy CJ, Bohm RP, Maness NJ, Fischer T, Rappaport J, Vaccari M. Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates. Nat Commun 2020;11:6078. [PMID: 33247138 DOI: 10.1038/s41467-020-19967-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 19.0] [Reference Citation Analysis]
173 Allen JC, Toapanta FR, Chen W, Tennant SM. Understanding immunosenescence and its impact on vaccination of older adults. Vaccine 2020;38:8264-72. [PMID: 33229108 DOI: 10.1016/j.vaccine.2020.11.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
174 Solforosi L, Kuipers H, Huber SKR, van der Lubbe JE, Dekking L, Czapska-casey DN, Gil AI, Baert MR, Drijver J, Vaneman J, van Huizen E, Choi Y, Vreugdenhil J, Kroos S, de Wilde AH, Kourkouta E, Custers J, Dalebout TJ, Myeni SK, Kikkert M, Snijder EJ, Barouch DH, Böszörményi KP, Stammes MA, Kondova I, Verschoor EJ, Verstrepen BE, Koopman G, Mooij P, Bogers WM, van Heerden M, Muchene L, Tolboom JT, Roozendaal R, Schuitemaker H, Wegmann F, Zahn RC. Immunogenicity and protective efficacy of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques.. [DOI: 10.1101/2020.11.17.368258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
175 Mok DZL, Chan CYY, Ooi EE, Chan KR. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection. FEBS J 2021;288:5055-70. [PMID: 33124149 DOI: 10.1111/febs.15613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
176 Schenkelberg T. Vaccine-induced protection in aging adults and pandemic response. Biochem Biophys Res Commun 2021;538:218-20. [PMID: 33213845 DOI: 10.1016/j.bbrc.2020.10.090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Shields AM, Faustini SE, Perez-Toledo M, Jossi S, Allen JD, Al-Taei S, Backhouse C, Dunbar L, Ebanks D, Emmanuel B, Faniyi AA, Garvey MI, Grinbergs A, McGinnell G, O'Neill J, Watanabe Y, Crispin M, Wraith DC, Cunningham AF, Drayson MT, Richter AG. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response. medRxiv 2020:2020. [PMID: 33236029 DOI: 10.1101/2020.11.12.20230763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
178 Cianci R, Franza L, Massaro MG, Borriello R, De Vito F, Gambassi G. The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines. Vaccines (Basel) 2020;8:E636. [PMID: 33147686 DOI: 10.3390/vaccines8040636] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
179 Schaenman J, Goldwater D. The aging transplant population and immunobiology: any therapeutic implication? Curr Opin Organ Transplant 2020;25:255-60. [PMID: 32374576 DOI: 10.1097/MOT.0000000000000760] [Reference Citation Analysis]
180 Guevara ML, Persano F, Persano S. Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy. Front Chem 2020;8:589959. [PMID: 33195094 DOI: 10.3389/fchem.2020.589959] [Cited by in Crossref: 75] [Cited by in F6Publishing: 84] [Article Influence: 25.0] [Reference Citation Analysis]
181 Zhang X, Mariano CF, Ando Y, Shen K. Bioengineering tools for probing intracellular events in T lymphocytes. Wiley Interdiscip Rev Syst Biol Med 2020;:e1510. [PMID: 33073545 DOI: 10.1002/wsbm.1510] [Reference Citation Analysis]
182 Pereira B, Xu XN, Akbar AN. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. Front Immunol 2020;11:583019. [PMID: 33178213 DOI: 10.3389/fimmu.2020.583019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 16.0] [Reference Citation Analysis]
183 Sharma L, Chang, Dela Cruz CS. Does inflammation help during COVID-19? ERJ Open Res 2020;6:00557-2020. [PMID: 33083436 DOI: 10.1183/23120541.00557-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
184 Sacco G, Célarier T, Gavazzi G, Annweiler C. Older adults should not be omitted from inclusion in clinical trials of SARS-CoV-2 vaccines. Maturitas 2021;146:63-4. [PMID: 33041157 DOI: 10.1016/j.maturitas.2020.10.002] [Reference Citation Analysis]
185 Dhama K, Patel SK, Kumar R, Rana J, Yatoo MI, Kumar A, Tiwari R, Dhama J, Natesan S, Singh R, Harapan H. Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond. Front Public Health 2020;8:574198. [PMID: 33072713 DOI: 10.3389/fpubh.2020.574198] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
186 Lung T, Kazatchkine MD, Risch L, Risch M, Nydegger UE. A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19. Transfus Apher Sci 2020;59:102936. [PMID: 32919880 DOI: 10.1016/j.transci.2020.102936] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
187 Rajaram S, Wojcik R, Moore C, Ortiz de Lejarazu R, de Lusignan S, Montomoli E, Rossi A, Pérez-Rubio A, Trilla A, Baldo V, Jandhyala R, Kassianos G. The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus. Vaccine 2020;38:6047-56. [PMID: 32600916 DOI: 10.1016/j.vaccine.2020.06.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
188 Walker JL, Grint DJ, Strongman H, Eggo RM, Peppa M, Minassian C, Mansfield KE, Rentsch CT, Douglas IJ, Mathur R, Wong AY, Quint JK, Andrews N, Bernal JL, Scott JA, Ramsay M, Smeeth L, Mcdonald H. UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records.. [DOI: 10.1101/2020.08.24.20179192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
189 González-Quijada S, Del Álamo-Martínez de Lagos M, Álvarez-Llabrés M, Pérez-González L. Cytomegalovirus antibody levels and mortality among hospitalised elderly patients. Ann Med 2020;52:497-505. [PMID: 32803995 DOI: 10.1080/07853890.2020.1811888] [Reference Citation Analysis]
190 Jurado A, Martín MC, Abad-Molina C, Orduña A, Martínez A, Ocaña E, Yarce O, Navas AM, Trujillo A, Fernández L, Vergara E, Rodríguez B, Quirant B, Martínez-Cáceres E, Hernández M, Perurena-Prieto J, Gil J, Cantenys S, González-Martínez G, Martínez-Saavedra MT, Rojo R, Marco FM, Mora S, Ontañón J, López-Hoyos M, Ocejo-Vinyals G, Melero J, Aguilar M, Almeida D, Medina S, Vegas MC, Jiménez Y, Prada Á, Monzón D, Boix F, Cunill V, Molina J. COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study. Immun Ageing 2020;17:22. [PMID: 32802142 DOI: 10.1186/s12979-020-00194-w] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
191 Noé A, Cargill TN, Nielsen CM, Russell AJC, Barnes E. The Application of Single-Cell RNA Sequencing in Vaccinology. J Immunol Res 2020;2020:8624963. [PMID: 32802896 DOI: 10.1155/2020/8624963] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
192 Bekeredjian-Ding I. Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections. Front Immunol 2020;11:1755. [PMID: 32849627 DOI: 10.3389/fimmu.2020.01755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
193 Fahlberg M, Blair R, Doyle-meyers L, Midkiff C, Zenere G, Russell-lodrigue K, Monjure C, Haupt E, Penney T, Lehmicke G, Threeton B, Golden N, Datta P, Roy C, Bohm R, Maness N, Fischer T, Rappaport J, Vaccari M. Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates.. [DOI: 10.1101/2020.07.21.213777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
194 Papagiannis D, Rachiotis G, Mariolis A, Zafiriou E, Gourgoulianis KI. Vaccination Coverage of the Elderly in Greece: A Cross-Sectional Nationwide Study. Can J Infect Dis Med Microbiol 2020;2020:5459793. [PMID: 32670440 DOI: 10.1155/2020/5459793] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
195 Damiot A, Pinto AJ, Turner JE, Gualano B. Immunological Implications of Physical Inactivity among Older Adults during the COVID-19 Pandemic. Gerontology 2020;66:431-8. [PMID: 32585674 DOI: 10.1159/000509216] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 15.0] [Reference Citation Analysis]
196 Chahine EB. High-Dose Inactivated Influenza Vaccine Quadrivalent for Older Adults. Ann Pharmacother 2021;55:89-97. [PMID: 32578447 DOI: 10.1177/1060028020935645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
197 Lambert EE, Corbière V, van Gaans-van den Brink JAM, Duijst M, Venkatasubramanian PB, Simonetti E, Huynen M, Diavatopoulos DD, Versteegen P, Berbers GAM, Mascart F, van Els CACM. Uncovering Distinct Primary Vaccination-Dependent Profiles in Human Bordetella Pertussis Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay. Vaccines (Basel) 2020;8:E225. [PMID: 32429152 DOI: 10.3390/vaccines8020225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
198 Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. Anesthesiology 2020;132:1346-61. [PMID: 32195698 DOI: 10.1097/ALN.0000000000003303] [Cited by in Crossref: 126] [Cited by in F6Publishing: 146] [Article Influence: 42.0] [Reference Citation Analysis]
199 Har-Noy M, Or R. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak. J Transl Med 2020;18:196. [PMID: 32398026 DOI: 10.1186/s12967-020-02363-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
200 Yurttutan S, İpek S, Güllü UU. Why the SARS-Cov-2 has prolonged spreading time in children? Pediatr Pulmonol 2020;55:1544-5. [PMID: 32356603 DOI: 10.1002/ppul.24795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Edelman R, Deming ME, Toapanta FR, Heuser MD, Chrisley L, Barnes RS, Wasserman SS, Blackwelder WC, Handwerger BS, Pasetti M, Siddiqui KM, Sztein MB. The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route. Immun Ageing 2020;17:9. [PMID: 32355503 DOI: 10.1186/s12979-020-00179-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
202 Wagner A, Weinberger B. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Front Immunol 2020;11:717. [PMID: 32391017 DOI: 10.3389/fimmu.2020.00717] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
203 Pawelec G, Weng NP. Can an effective SARS-CoV-2 vaccine be developed for the older population? Immun Ageing 2020;17:8. [PMID: 32300370 DOI: 10.1186/s12979-020-00180-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
204 Zhavoronkov A. Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections. Aging (Albany NY) 2020;12:6492-510. [PMID: 32229705 DOI: 10.18632/aging.102988] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
205 Velipaşaoğlu S. Aşı immünitesi ve yanıtını etkileyen faktörler. OSMANGAZİ JOURNAL OF MEDICINE 2020. [DOI: 10.20515/otd.676787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
206 Avchaciov K, Antoch MP, Andrianova EL, Tarkhov AE, Menshikov LI, Burmistrova O, Gudkov AV, Fedichev PO. Identification of a blood test-based biomarker of aging through deep learning of aging trajectories in large phenotypic datasets of mice.. [DOI: 10.1101/2020.01.23.917286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
207 Cassimos DC, Effraimidou E, Medic S, Konstantinidis T, Theodoridou M, Maltezou HC. Vaccination Programs for Adults in Europe, 2019. Vaccines (Basel) 2020;8:E34. [PMID: 31968652 DOI: 10.3390/vaccines8010034] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
208 Vadasz Z, Toubi E. Immune Responses in the Elderly. Rheumatic Disease in Geriatrics 2020. [DOI: 10.1007/978-3-030-44234-7_4] [Reference Citation Analysis]
209 Souliotis VL, Vlachogiannis NI, Pappa M, Argyriou A, Ntouros PA, Sfikakis PP. DNA Damage Response and Oxidative Stress in Systemic Autoimmunity. Int J Mol Sci 2019;21:E55. [PMID: 31861764 DOI: 10.3390/ijms21010055] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
210 [DOI: 10.1101/2021.03.03.21251066] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Reference Citation Analysis]
211 [DOI: 10.1101/2020.06.29.20142505] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Reference Citation Analysis]